KEY POINTS:
Up to $12 million will be available for investing in biotechnology under a new investment partnership.
The partnership involves Crown-owned company New Zealand Venture Investment Fund (NZVIF) and private investment company Pacific Channel, the New Zealand affiliate of United States life sciences venture firm The Channel Group.
Together
